who we are
what we do
expert insights
contact us

who we are
what we do
expert insights
contact us

Blog

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Trials, Innovations

Viralgen Vector Core and Elpida Therapeutics partner to manufacture gene therapy medicines for anticipated Spastic Paraplegia 50 (SPG50) and Charcot-Marie-Tooth disease type 4J (CMT4J) clinical trials

Viralgen

Sep 29, 2023 12:00:00 AM

Viralgen Vector Core and Elpida Therapeutics partner to manufacture gene therapy medicines for antic...

Drive people to your products and services

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

VIRALGEN VECTOR CORE

Paseo Mikeletegi, 83
20009 San Sebastián, Spain

Tel: +34 943 47 77 33

VIRALGEN COMMERCIAL THERAPEUTIC

Paseo Mikeletegi, 8
20009 San Sebastián, Spain

Tel: +34 943 47 77 33

WHO WE ARE

WHAT WE DO

EXPERT INSIGHTS

CONTACT US

In-White-128@2x 1

Policies

Privacy Policy Cookie Policy Cookie Preferences Personal Data Protection Information Security Policy Whistleblower Channel

© VIRALGEN 2024. All rights reserved

Please review the following rules: